-- 4DMedical(ASX:4DX)は、火曜日にオーストラリア証券取引所に提出した書類によると、ステート・ストリートとその子会社が4月24日に同社の株式の5.01%、すなわち2960万株を取得し、主要株主になったと発表した。
Related Articles
Ping An Insurance's Q1 Profit Slips 7.4%
Ping An Insurance (SHA:601318, HKG:2318) recorded a 7.4% decline in attributable profit in the first quarter of 2026 to 25 billion yuan from 27 billion yuan a year prior, according to a Tuesday Hong Kong bourse filing.Earnings per share slipped to 1.25 yuan from 1.44 yuan in the corresponding period of the previous fiscal year.The insurer's total revenue slid 7.1% to 238.5 billion yuan from 256.6 billion yuan in the year-ago period.
Zephirin Raises Price Target on SLB to $43 From $41, Keeps Sell Rating, Medium Risk
SLB (SLB) has an average rating of overweight and mean price target of $59.78 according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Research Alert: Alle: Q1 Short Of Consensus, But Maintains 2026 Guidance
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Allegion (ALLE) posted Q1 adjusted EPS of $1.80 vs. $1.86 (-3%), $0.10 short of consensus. Net sales rose 9.7% Y/Y (+2.6% organically) to $1.03B ($10M ahead of consensus). The organic revenue increase was driven by price realizations partially offset by volume declines. The reported revenue increase also reflects a 4.8% net positive impact from acquisitions and divestitures, as well as a 2.3% tailwind from foreign currency. Adjusted operating margin contracted 150 bps to 21.2% due to headwinds from volume declines and price and productivity net of inflation and investment (PPII). During Q1, ALLE repurchased 0.3M shares for $40M and paid dividends of $47M (a quarterly dividend of $0.55 per share). Management maintained prior full year 2026 guidance, including adjusted EPS in the range of $8.70-$8.90. Shares are currently trading 4% lower in pre-market trading on the earnings miss - its second in a row following a streak in which its bottom line had not fallen short of consensus since 2019.